E. Vichinsky

Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with Hb SS and beta thalassemia.

D. Faller, E. Vichinsky, T. Papayannopoulou, 1989, Blood.

A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.

D. Faller, H. Witkowska, N. Olivieri, 1993, The New England journal of medicine.

Sample suitability for the detection of minor white cell populations (microchimerism) by polymerase chain reaction

B. Lubin, E. Vichinsky, W. Reed, 2008, Transfusion.

Correction of the anemia of epidermolysis bullosa with intravenous iron and erythropoietin.

E. Vichinsky, J. Fridge, 1998, The Journal of pediatrics.

Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders.

D. Faller, E. Vichinsky, N. Olivieri, 1994, The American journal of pediatric hematology/oncology.

Universal newborn screening for Hb H disease in California.

H. Witkowska, J. Waye, F. Farina, 2001, Genetic testing.

Hemoglobin Hakkari: An autosomal dominant form of beta thalassemia with inclusion bodies arising from de novo mutation in exon 2 of beta globin gene

F. Hazard, F. Kuypers, E. Vichinsky, 2010, Pediatric blood & cancer.

S116: LONG-TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE KINASE ACTIVATOR MITAPIVAT IN ADULTS WITH NON—TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA

A. Lal, H. Al‐Samkari, D. Layton, 2021, HemaSphere.